InMed Pharmaceuticals Inc (INM): Very smart move on your part, anyone who...

Send PM Follow Ignore

Followers	52
Posts	601
Boards Moderated	0
Alias Born	05/25/2014

PharmaGreen007

Re: wholelotamoney post# 28

Thursday, 05/29/2014 3:52:18 PM

Thursday, May 29, 2014 3:52:18 PM

Very smart move on your part, anyone who's currently following your investments who follows your lead is going to be very happy with you to say the least smile

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent INM News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/27/2026 08:08:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 09:08:05 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:51:08 PM
/C O R R E C T I O N -- InMed Pharmaceuticals/ • PR Newswire (US) • 05/20/2026 02:34:00 PM
/C O R R E C T I O N -- InMed Pharmaceuticals/ • PR Newswire (US) • 05/19/2026 06:21:00 PM
InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM) • IH Market News • 05/19/2026 02:37:16 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/19/2026 02:34:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 02:32:30 PM
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies • PR Newswire (US) • 05/19/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 10:03:08 AM
InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 05/19/2026 10:00:00 AM
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update • Newsfile • 05/06/2026 10:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 09:25:11 PM
InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 04/27/2026 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:58:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:19:20 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 08:17:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:37:48 PM
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance • Newsfile • 03/27/2026 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:26 AM
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program • Newsfile • 03/23/2026 11:30:00 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
Sidoti Events, LLC's March Small-Cap Virtual Conference • ACCESS Newswire • 03/18/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:44 AM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent INM News

More INM News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent INM News

Go Ad-Free